- Healthy Extracts Inc. recently declared its 2020 Q4 results showing an exponential revenue increase of 71% from last year
- The company’s proprietary Fuel4Thought(TM) Brain Booster product is undergoing clinical testing, and is slated for release in Q2
- Healthy Extracts, Inc.(TM) officially changed its name from Grey Cloak Tech Inc. on March 1, 2020
Healthy Extracts (OTCQB: HYEX), is a leading researcher and manufacturer of plant-based formulations whose objective is to offer a better lifestyle through superior heart and brain health technology. The company is focused on strengthening and expanding its market reach through its science-based wholly-owned subsidiaries BergaMet North America (BergaMet NA) and Ultimate Brain Nutrients (“UBN”).
In a recent announcement by Healthy Extracts, the company revealed its year-end financial reports for the year ending Dec. 31, 2020. Financial highlights of the report include revenue increases of 71% to $1,276,559 compared to 2019 revenues of $748,377. Healthy Extracts attributes its revenue boom to its adaptation of selling health-nutrition products (https://ibn.fm/dfuzj).
There has been a worldwide increase in health concerns due to the COVID-19 pandemic, greenhouse gas emissions, and the increased environmental pressure due to animal rearing. The plant-based food industry is expected to reach a value of $74.2 billion in 2027, guided by a CAGR of 11.9% from 2020 to 2027. These results are supplemented by a 2020 study by the Yale Program on Climate Change Communication, whose findings suggest that despite only 4% of the population being vegans or vegetarians, 94% of Americans are inclined towards plant-based foods (https://ibn.fm/RIx6b).
Kevin Duke Pitts, Director, President, and CEO of HYEX stated that Healthy Extracts officially changed its name from Grey Cloak Tech Inc. on March 1, 2020, to reflect its business line of operations. The company currently operates through its two subsidiaries, having shut down Eqova in 2019.
Healthy Extracts acquired BergaMet NA in 2019, engaged in selling and distributing a full line of proprietary product formulations derived from the rare Citrus Bergamot Superfruit(TM) (“bergamot”) native to Southern Italy. With its natural source of various antioxidant polyphenols, Bergamot has anti-inflammatory properties, reduces cholesterol, and is being touted as an effective heart health supplement. UBN develops unique, plant-based superior proprietary neuro-brain solutions that enhance the brain’s overall health.
Some other business highlights for 2020 include a full reporting and upgrade to the OTCQB, the acquisition of Ultimate Brain Nutrients, and the introduction of two key products: BergaMetNA Clinical Immune and BergaMetnNA HerHeart. Clinical testings are ongoing in full-swing on the company’s proprietary Fuel4Thought Brain Booster product, which is slated for release in Q2 (https://ibn.fm/Ac5Af).
For more information, visit the company’s website at www.HealthyExtractsInc.com.
NOTE TO INVESTORS: The latest news and updates relating to HYEX are available in the company’s newsroom at https://ibn.fm/HYEX
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
